SureTrader Advertisement SureTrader
Home > Boards > Canadian > Biotechs >

Trillium Therapeutics Inc. (TRIL)

TRIL RSS Feed
Add TRIL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 4/22/2016 11:46:59 AM - Followers: 32 - Board type: Free - Posts Today: 0

    
                                  

Stem Cell Therapeutics (SCTPF or SSS.V)

 

Stem Cell Therapeutics

http://www.stemcellthera.com/

 

Stem Cell Therapeutics Corp.

Suite 1000, 1520 - 4th Street SW

Calgary, Alberta, Canada T2R1H5

Phone: 403.245.5495

Fax: 403.245.5411

 

About Stem Cell Therapeutics Corp.: Stem Cell Therapeutics Corp. is a public biotechnology company (TSX VENTURE:SSS) focused on the development and commercialization of drug-based therapies to treat central nervous system diseases. SCT is a leader in the development of therapies that utilize drugs to stimulate a patient's own resident stem cells. The Company's programs aim to repair brain and nerve function lost due to disease or injury. The Company's extensive patent portfolio of owned and licensed intellectual property supports the potential expansion into future clinical programs in numerous neurological diseases such as traumatic brain injury, multiple sclerosis, Huntington's disease, Alzheimer's disease, and ALS.

 

REASONS TO INVEST IN STEM CELL THERAPEUTICS

http://www.stemcellthera.com/IR.aspx

 

 

Press Releases:

 

 

DEC 11, 2009 - Stem Cell Therapeutics Corp. Adds Another U.S. Patent to Its Intellectual Property Portfolio

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1089614&year=2009&releaseSeq=0

 

Dec 10, 2009 - Stem Cell Therapeutics Corp. Announces Additional U.S. Patent

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1088967&year=2009&releaseSeq=0

 

Nov 25, 2009 - Stem Cell Therapeutics Corp. Announces Regenerative Medicine Panel Discussion led by Dr. Allen Davidoff

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1081994&year=2009&releaseSeq=0

 

Nov 23, 2009 - Stem Cell Therapeutics Corp. Announces Third Quarter Financial Results

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1080555&year=2009&releaseSeq=0

 

Nov 20, 2009 - Stem Cell Therapeutics Corp. Announces Positive Review by Data Safety and Monitoring Board for the Phase IIb Stroke Trial

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1079955&year=2009&releaseSeq=0

 

Nov 12, 2009 - Stem Cell Therapeutics Corp. Announces That Dr. Allen Davidoff Will Present at the 2009 Neural Restoration Workshop Series

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1075491&year=2009&releaseSeq=0

 

Oct 29, 2009 - Stem Cell Therapeutics Corp. Closes Financing for $2,186,941

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1068127&year=2009&releaseSeq=0

 

Oct 08, 2009 - Stem Cell Therapeutics Corp. Announces Private Placement

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1056964&year=2009&releaseSeq=0

 

Oct 02, 2009 - Stem Cell Therapeutics Corp.: Dr. Alan Moore Will Present the Company's Brain and Neural Regeneration Therapy for the Treatment of Stroke and Multiple Sclerosis at the 2009 Banff Venture Forum

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1053981&year=2009&releaseSeq=0

 

Sep 23, 2009 - Stem Cell Therapeutics Corp. Announces That Dr. Alan Moore Will Present a Novel, Drug-Based Approach to Neuron Regeneration at the 2009 World Stem Cell Summit

http://cnrp.ccnmatthews.com/client/stem_cell_therapeutics/release.jsp?actionFor=1048957&year=2009&releaseSeq=1

 

 

-----------------------------------------------------------
 

 

 

Sedar   http://www.sedar.com/homepage_en.htm

 

TMX.  http://www.tmx.com/

 

TMXmoney   http://www.tmxmoney.com/en/index.html

 

CNW Group Newswire   http://www.cnxmarketlink.com/en/index.cgi

 

Canadian Insider

http://canadianinsider.com/coReport/allTransactions.php?ticker=sss

 
Currency Converter:
http://www.bankofcanada.ca/en/rates/converter.html

 

FOR FURTHER INFORMATION PLEASE CONTACT:

Stem Cell Therapeutics Corp.
Alan Moore, PhD
President and CEO
(403) 245-5495 ext.224
amoore@stemcellthera.com


or


Stem Cell Therapeutics Corp.
Chloe Douglas-Crampton
Investor Relations
(403) 245-5495 ext. 221
crampton@stemcellthera.com
www.stemcellthera.com

 

 -----------------------------------------------------------
 

Financial Reports:
http://www.stemcellthera.com/IR.aspx?section=reports

 

CHART is for Canadian ticker.  Remember to adjust for exchange rate.

Currency Converter:  http://www.bankofcanada.ca/en/rates/converter.html



Using chart for Canadian ticker until Stockcharts adds SCTPF to their database.

 

 

 [chart]stockcharts.com/c-sc/sc?s=SSS.V&p=D&b=5&g=0&i=p21248829804&a=189138722&r=1945[/chart]



All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Last update 4.13.2010

 

Rules of the board according to IHUB:
http://www.investorshub.com/boards/complex_terms.asp

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TRIL
Current Price
Volume:
Bid Ask Day's Range
Wiki
SureTrader
TRIL News: Report of Foreign Issuer (6-k) 04/21/2016 07:02:25 AM
TRIL News: Report of Foreign Issuer (6-k) 04/14/2016 07:23:13 AM
TRIL News: Report of Foreign Issuer (6-k) 04/12/2016 07:04:44 AM
TRIL News: Report of Foreign Issuer (6-k) 03/23/2016 07:09:11 AM
TRIL News: Report of Foreign Issuer (6-k) 03/22/2016 06:03:29 AM
PostSubject
#193   We'll soon see jondoeuk 04/22/16 11:46:58 AM
#192   Well, I guess I lost our little side RockRat 04/20/16 03:38:10 PM
#191   Hoping results are strong. I would think they ronpopeil 04/20/16 09:28:53 AM
#190   Stanford is presenting human cd47 data at ASCO super_trades 04/20/16 09:18:31 AM
#189   Immuno-Oncology Combinations NY1972 04/18/16 09:11:41 PM
#188   This implied MTD was found earlier than expected NY1972 04/17/16 12:25:56 PM
#187   That's odd??. The info from the clinicaltrials.gov site jondoeuk 04/17/16 12:14:40 AM
#186   Pac-Man at Stanford, why P1 stopped at 20?? NY1972 04/16/16 11:22:58 PM
#185   anti-CSF-1R (c-fms) antibody NY1972 04/16/16 10:43:10 PM
#184   Ox40 Eleven of 70 pts (16%) have been NY1972 04/16/16 10:40:41 PM
#183   Bought some nice cash and science low floater akamaii 04/14/16 01:22:30 PM
#182   Fusion between cancer cells and macrophages NY1972 04/14/16 11:59:11 AM
#181   CD163/CD68 ratio (an indicator of M2 polarisation) was NY1972 04/07/16 03:05:43 PM
#180   Close-up of pancreatic cancer cells, why the smaller NY1972 04/07/16 02:10:09 PM
#179   I am out. WarrenE 04/06/16 02:54:23 PM
#178   13G filings NY1972 04/06/16 11:38:20 AM
#177   combinations will dominate treatment strategies, probably starting with NY1972 04/05/16 12:20:30 PM
#176   microglia acts like TAM NY1972 04/05/16 11:02:55 AM
#175   Hopefully it goes up another 20% .. WarrenE 04/04/16 01:38:14 PM
#174   TAM and breast cancer NY1972 04/04/16 01:22:34 PM
#173   MCSF-polarized M2 macrophages as well as CSC-conditioned NY1972 04/04/16 12:25:04 PM
#172   TAMs facilitate almost every step of the metastatic NY1972 04/03/16 05:30:27 PM
#171   combination of immunotherapy and radiation therapy NY1972 04/03/16 11:45:27 AM
#170   PC and immune therapies NY1972 04/03/16 11:21:28 AM
#169   Cabozantinib is a potent targeted therapy that inhibits MET NY1972 04/03/16 11:00:00 AM
#168   Expression of mouse CD47 on human cancer cells NY1972 04/02/16 10:50:46 PM
#167   Innate immunity NY1972 04/02/16 09:54:04 PM
#166   Holding a small position. Would be a RockRat 04/01/16 05:24:25 PM
#165   Rockrate What are the chances that TRIL will accept DFRAI 04/01/16 01:21:10 PM
#164   Rockrat So what is your feeling on holding it? DFRAI 04/01/16 01:18:28 PM
#163   >>I am speculating that we will see Phase RockRat 04/01/16 01:15:46 PM
#162   CD47 / MET strongly associated with lymph node metastasis NY1972 04/01/16 11:11:09 AM
#161   CD47 and pancreatic neuroendocrine tumors NY1972 04/01/16 11:03:24 AM
#160   CC-90002 – exploring optimization of CD47 target promise: NY1972 03/31/16 10:03:54 PM
#159   Rockrat I am speculating that we will see Phase DFRAI 03/31/16 05:21:33 PM
#158   CD47 and infections NY1972 03/30/16 11:58:09 AM
#157   A single treatment with chemotherapy before, rather than NY1972 03/24/16 09:29:26 PM
#156   75 millions for combo studies after seeing P1 NY1972 03/24/16 12:45:16 PM
#155   Dug around in AACR. Notes here: RockRat 03/23/16 06:47:16 PM
#154   correction: 23K buy not 32K NY1972 03/23/16 10:58:36 AM
#153   32K CMO buy. Did he see P1 data?? NY1972 03/23/16 10:56:42 AM
#152   Meeting Type : Annual General and Special Meeting NY1972 03/22/16 01:22:27 PM
#151   AACR next month DFRAI 03/22/16 12:43:57 PM
#150   Other studies focused on the genetic characterization of NY1972 03/21/16 11:47:42 AM
#149   Hu5F9-G4 has substantial efficacy in MES-OV OCX, and NY1972 03/20/16 03:29:58 PM
#148   Blockade of CD47 on the tumor cells using NY1972 03/20/16 02:59:36 PM
#147   Just trying to keep this board alive with NY1972 03/20/16 01:08:05 AM
#146   NY1972 I saw you posted some recent info and DFRAI 03/19/16 12:42:18 PM
#145   NI-1701 Neutralization of CD47 in cancer cells with NY1972 03/17/16 12:51:52 AM
#144   High-throughput matrix screening reveals synergistic chemotherapeutic combinatio NY1972 03/17/16 12:33:05 AM
PostSubject